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AbstrACt
Objectives To investigate recorded poor insight in relation 
to mental health and service use outcomes in a cohort 
with first-episode psychosis.
Design We developed a natural language processing 
algorithm to ascertain statements of poor or diminished 
insight and tested this in a cohort of patients with first-
episode psychosis.
setting The clinical record text at the South London and 
Maudsley National Health Service Trust in the UK was 
used.
Participants We applied the algorithm to characterise 
a cohort of 2026 patients with first-episode psychosis 
attending an early intervention service.
Primary and secondary outcome measures Recorded 
poor insight within 1 month of registration was investigated 
in relation to (1) incidence of psychiatric hospitalisation, 
(2) odds of legally enforced hospitalisation, (3) number of 
days spent as a mental health inpatient and (4) number of 
different antipsychotic agents prescribed; outcomes were 
measured over varying follow-up periods from 12 months 
to 60 months, adjusting for a range of sociodemographic 
and clinical covariates.
results Recorded poor insight, present in 48.9% of the 
sample, was positively associated with youngest and 
oldest age groups, unemployment and schizophrenia 
(compared with bipolar disorder) and was negatively 
associated with Asian ethnicity, married status, home 
ownership and recorded cannabis use. It was significantly 
associated with higher levels of all four outcomes over the 
succeeding 12 months. Associations with hospitalisation 
incidence and number of antipsychotics remained 
independently significant when measured over 60 and 
48 months, respectively.
Conclusions Recorded poor insight in people with recent 
onset psychosis predicted higher subsequent inpatient 
mental healthcare use. Improving insight might benefit 
patients’ course of illness as well as reduce mental health 
service use.
IntrODuCtIOn
Schizophrenia and other psychotic disorders 
have potentially severe impacts both on indi-
viduals and society, although their course and 
prognosis are variable. The concept of insight 
has historically been challenging to define 
and measure. Currently, researchers and 
clinicians use long and short cognitive and 
clinical assessment schedules which measure 
unidimensional and multidimensional 
aspects of insight such as awareness of illness 
and its consequences, attribution of symp-
toms, acceptance of treatment and under-
standing of its effects1 2 as well as cognitive 
notions such as self-reflection and self-cer-
tainty.3 Other views additionally propose that 
insight depends on cognitive functioning and 
on a patient’s cultural and life experiences 
that cannot accurately be measured through 
traditional objective assessments.4
The awareness and appreciation by an 
individual of their psychopathology has long 
been considered a determinant of outcome. 
Patients with poor insight are less likely to 
understand their illness; hence, have been 
found to be less likely to adhere to treat-
ment5–7 and/or require more extensive 
treatment.8 Many studies have concluded 
that poor insight is associated with stigma 
and worse social performance; however, 
some have claimed that insight is not in fact 
directly linked to the outcome of the illness 
but how it is progressing.9 Self-reported 
strengths and limitations of this study
 ► Our study included a large sample size, followed a 
naturalistic method of cohort identification and fol-
low-up and applied natural language processing, a 
novel text extraction method, to ascertain insight.
 ► Measurement of insight (as a binary fixed variable) 
depended on this clearly having been stated in the 
clinical record and cannot be assumed to be identi-
cal to assessment through interview.
 ► Follow-up assessments were only feasible for those 
cases remaining in the geographic catchment area 
served by the Trust.
 ► Causal pathways between insight and clinical out-
comes cannot be determined by our analysis.
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quality of life has been found to be higher in patients 
with poor insight; this has been suggested as secondary 
to delusional beliefs,10 11 although good insight has been 
found to be associated with higher risk of depression in 
people with schizophrenia12 and with suicidality.13 14 On 
the other hand, poor insight in schizophrenia has been 
associated with higher anxiety,15 with obsessive/compul-
sive symptoms,16 and with violent behaviour in some17 but 
not in all18 studies. In mania, poor insight has been asso-
ciated with elation rather than irritability or psychosis.19 
However, others have concluded that there are no associ-
ations of insight either with symptoms or progression of 
schizophrenia.20
Despite the range of studies exploring insight in 
psychotic disorders, we could find no direct investiga-
tions of associations with service use outcomes. In a large 
mental healthcare data resource, we therefore sought 
to develop a means of extracting descriptions of insight 
from the text fields of clinical records and investigated 
whether recorded poor insight early after a first clinical 
presentation with psychosis predicted increased subse-
quent service use.
MethODs
setting and data sources
The data used in this study were obtained from the South 
London and Maudsley National Health Service Foun-
dation Trust (SLaM), one of Europe’s largest mental 
healthcare organisations which provides comprehen-
sive services across all ages and specialties to a defined 
geographic catchment of around 1.2 million residents 
within four south London boroughs (Lambeth, South-
wark, Lewisham and Croydon). SLaM has used fully elec-
tronic health records for over 10 years and its Clinical 
Record Interactive Search (CRIS) tool, set up in 2008,21 22 
allows researcher access to deidentified data from the full 
record within a robust governance framework.23
exposure of interest and data extraction
CRIS has been substantially enhanced through natural 
language processing algorithms applied to extract 
constructs of interest from text fields in the source record 
using information extraction/named entity recognition 
techniques.22 24 For this study, Text Hunter annotation 
software25 was used to create training and test corpora clas-
sifying mentions of insight in the clinical record to train a 
supervised machine learning algorithm to recognise this 
automatically across the wider sample. An initial keyword 
search was carried out to extract sentences containing the 
word ‘insight’, and a human annotator manually catego-
rised these as either ‘good insight’ (for example, when 
insight was described as ‘clear’, ‘improving’, ‘partial’, 
‘good’, ‘insightful’, ‘present’, ‘intact’ and ‘aware’), ‘poor 
insight’ (eg, described as ‘lacking’, ‘poor’, ‘limited’, 
‘insightless’, ‘absent’, ‘impaired’, ‘lost’ or words to that 
effect) or as not relevant (ie, unclear/lengthy descrip-
tions, unassessed insight, insight mentioned as a future 
goal rather that at the present or where the level of insight 
was not immediately obvious). For generating training 
and independent test sets the algorithm, a randomly 
selected 1814 relevant sentences were manually anno-
tated from all patients on CRIS with a previous diagnosis 
of schizophreniform or affective disorder (International 
Classification of Diseases 10th Revision (ICD-10) F2x or 
F3x), of which 788 were classified as having good insight, 
826 as having poor insight and 200 as non-relevant state-
ments. Precision (positive predictive value) and recall 
(sensitivity) were used as performance metrics based on 
conventional practice in text extraction evaluation.26 The 
algorithm generated classified ‘poor insight’ instances 
with 0.73 precision (positive predictive value) and 0.83 
recall (sensitivity) against the manual gold standard.
Participants
For the analysis, a database was used which had been 
previously prepared via CRIS for an analysis of psychosis 
outcomes associated with cannabis use.27 In summary, 
this comprised all 2026 individuals with first-episode 
psychosis who were accepted by a SLaM early interven-
tion (EI) service between 1 April 2006 and 31 March 
2013. Criteria for accepting patients in SLaM EI services 
follow those outlined in the ‘Standards for Early Inter-
vention in Psychosis Services—First Edition’.28 Outcome 
data were collected up to 31 March 2014. All participants 
were assessed for outcomes within 12 months of the 
date of being accepted to an early intervention service 
(2026 person-years). Participants with sufficient follow-up 
data were also assessed for outcomes within 24 months 
(n=1738; 3476 person-years), 36 months (n=1461; 4383 
person-years), 48 months (n=1185; 4740 person-years) 
and 60 months (n=926; 4630 person-years). Predictor, 
covariate and outcome variable data were obtained via 
CRIS. Besides insight, the following covariates were ascer-
tained using values recorded closest to the date of being 
accepted by an early intervention service: age, gender, 
ethnicity, marital status, employment status and type of 
accommodation, primary diagnosis and cannabis use. 
Ethnicity was recorded according to categories defined by 
the UK Office for National Statistics and was condensed 
for this analysis into four groups (white, black, Asian, 
other). Diagnosis was recorded using the ICD-10 classi-
fication system. The derivation of cannabis use through 
natural language processing and its application as a 
covariate have been previously described.27 Using the 
natural language processing algorithm described above, 
recorded poor insight was ascertained from case records 
within 1 month either side of the date each patient was 
accepted to the early intervention service, and this was 
defined as the primary exposure.
Outcomes
We investigated the association between poor insight and 
the following mental healthcare outcomes: (1) number 
of psychiatric hospital admission, (2) any legally enforced 
(compulsory) admission under the UK Mental Health 
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Act (MHA), (3) the number of unique antipsychotics 
prescribed (as a proxy measure of treatment failure) 
and (4) the number of days spent in psychiatric hospital 
over a given follow-up period. The MHA is a UK statute 
law which allows compulsory admission for up to 28 days 
(‘Section 2’) or up to 6 months (‘Section 3’). Antipsy-
chotics used were ascertained both from structured fields 
and a natural language processing algorithm.22
statistical analysis
All participants were assessed for outcomes within 
12 months of the date of being accepted to an early 
intervention service. Those with sufficient follow-up data 
were then also assessed for outcomes within 24, 36, 48 
and 60 months of this first acceptance date (ie, different 
but overlapping follow-up periods). This was an identical 
approach to that previous adopted for analyses in these 
data,27 investigating discrete periods of follow-up time 
rather than using survival analysis because of the non-pro-
portionality of hazards. The sample was first described 
and factors associated with poor insight investigated. 
Regression models were then used to evaluate unad-
justed and successively adjusted associations with the four 
outcomes over the five different follow-up periods. Owing 
to overdispersion, previously described for these data,27 
we aimed to assess associations with number of hospital 
admissions and number of unique antipsychotic medi-
cations using multivariable negative binomial regression 
(zero inflation having been investigated but giving rise to 
no meaningful difference). However, one of the models 
failed to converge, and so Poisson regressions were used 
instead. Associations with legally enforced hospitalisa-
tion were assessed using multivariable binary logistic 
regression. Associations with number of inpatient days 
within given observation periods were investigated using 
multiple linear regression models. Reference groups for 
covariates were defined as those with the highest prev-
alence for each variable, and missing categories were 
included as predictor variables so that no patients were 
excluded because of missing covariate data. Stata soft-
ware V.13 (StataCorp Stata Statistical Software: Release 
13; StataCorp, 2011) was used.
Patient and public involvement
We did not directly incorporate patient and public 
involvement (PPI) into this particular analysis, but the 
SLaM Biomedical Research Centre Case Register used in 
the study was developed with extensive PPI and is over-
seen by committees that include service user and general 
public representatives.
results
Patients
From the cohort of 2026 individuals, 991 (48.9%) had 
at least one recording of poor insight within 1 month 
either side of their registration with the early intervention 
service. The sample characteristics and their associations 
with recorded poor insight are summarised in table 1. This 
was more common in the youngest and oldest members 
of the cohort, in those who were recorded as being a 
student or unemployed and in those not recorded as 
using cannabis. It was least common in patients of Asian 
ethnicity, in those who were married and in homeowners. 
Poor insight was most commonly recorded in schizoaf-
fective disorder, schizophrenia and ‘other’ diagnosis and 
least common in bipolar disorder.
unadjusted and adjusted main outcomes
Associations with service use outcomes in unadjusted 
and multivariable analyses are described in tables 2–5. 
Table 1 Sample characteristics and associations with poor 
insight (n=2026)
Variable Category Number
% poor 
insight
χ2(df) 
P value
Age <16 19 73.68 9.64 (3)
0.02216–25 1234 50.32
26–35 747 45.65
>35 26 57.69
Gender Male 1295 50.12 2.07 (1)
0.150Female 731 46.79
Ethnicity White 616 49.19 8.22 (3)
0.042Asian 126 38.10
Black 1005 50.85
Other 279 46.24
Relationship Married 153 39.87 19.20 (3)
<0.001Divorced 63 55.56
Single 1727 48.52
Not recorded 83 68.67
Employment Employed 107 49.53 33.61 (3)
<0.001Student 144 57.64
Unemployed 427 59.48
Not recorded 1348 44.58
Accommodation Owner 14 28.57 97.78 (6)
<0.001Private tenant 83 56.63
Council tenant 162 53.09
Supported 19 68.42
Homeless 37 51.35
Other 450 67.11
Not recorded 1261 41.24
Primary 
diagnosis
Schizophrenia 1097 47.86 27.31 (5)
<0.001Bipolar 100 30.00
Depression 94 44.68
Schizoaffective 35 54.29
Drug-induced 
psychosis
63 39.68
Other 637 54.95
History of 
cannabis use
No 1087 58.97 94.90 (1)
<0.001Yes 939 37.27
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Adjusted associations of recorded poor insight with 
higher numbers of hospitalisation episodes (table 2) 
were strongest when evaluated within 12 or 24 months of 
first referral, fell below statistical significance for analyses 
of 36 and 48-month follow-up periods but strengthened 
again for the 60-month estimation, although coefficients 
did not vary substantially. Higher odds of legally enforced 
hospitalisations were most strongly associated with 
poor insight when evaluated within the first 12 months 
(table 3), although remained raised at borderline signif-
icance for a number of the other time periods. Higher 
number of unique antipsychotics prescribed was also 
Table 2 Association between poor insight and number of hospital admissions (negative binomial regression)
Incidence rate ratio for the association with insight (95% CIs, p value)
Time period 
evaluated Unadjusted
Adjusted age and 
gender
Adjusted age, 
gender, ethnicity, 
relationship
Adjusted age, 
gender, ethnicity, 
relationship, 
employment, 
accommodation
Adjusted age, 
gender, ethnicity, 
relationship, 
employment, 
accommodation, 
diagnosis
12 months n=2026 1.37
(1.12 to 1.67) 0.002
1.38
(1.13 to 1.69) 0.001
1.36
(1.11 to 1.67) 0.003
1.41
(1.14 to 1.74) 0.001
1.37
(1.11 to 1.70)
0.004
24 months n=1738 1.41
(1.15 to 1.71)
0.001
1.42
(1.17 to 1.74)
<0.001
1.42
(1.17 to 1.74)
0.001
1.46
(1.19 to 1.80)
<0.001
1.38
(1.12 to 1.71)
0.003
36 months n=1461 1.26
(1.02 to 1.55)
0.031
1.28
(1.03 to 1.58)
0.024
1.29
(1.04 to 1.60)
0.022
1.32
(1.06 to 1.65)
0.015
1.22
(0.97 to 1.54)
0.083
48 months n=1185 1.30
(1.03 to 1.63)
0.029
1.32
(1.04 to 1.66)
0.021
1.36
(1.07 to 1.73)
0.013
1.36
(1.06 to 1.74)
0.015
1.28
(1.00 to 1.65)
0.053
60 months n=926 1.32
(1.01 to 1.73)
0.042
1.34
(1.02 to 1.76)
0.035
1.47
(1.10 to 1.95)
0.008
1.46
(109 to 1.95)
0.011
1.37
(1.02 to 1.85)
0.036
Table 3 Association between insight and legally enforced hospitalisation* (logistic regression)
OR for the association with insight (95% CIs, p value)
Time period 
evaluated Unadjusted
Adjusted age and 
gender
Adjusted age, 
gender, ethnicity, 
relationship
Adjusted age, 
gender, ethnicity, 
relationship, 
employment, 
accommodation
Adjusted age, 
gender, ethnicity, 
relationship, 
employment, 
accommodation, 
diagnosis
12 months n=2026 1.41
(1.13 to 1.75)
0.002
1.41
(1.14 to 1.76)
0.002
1.40
(1.12 to 1.74)
0.003
1.42
(1.13 to 1.78)
0.003
1.34
(1.07 to 1.69)
0.012
24 months n=1738 1.35
(1.10 to 1.67)
0.005
1.36
(1.10 to 1.67)
0.004
1.36
(1.10 to 1.68)
0.005
1.38
(1.10 to 1.72)
0.004
1.29
(1.03 to 1.62)
0.025
36 months n=1461 1.24
(0.99 to 1.54)
0.058
1.25
(1.00 to 1.55)
0.051
1.26
(1.01 to 1.58)
0.042
1.29
(1.02 to 1.62)
0.033
1.20
(0.95 to 1.53)
0.125
48 months n=1185 1.26
(0.99 to 1.61)
0.056
1.29
(1.01 to 1.64)
0.041
1.33
(1.04 to 1.71)
0.024
1.37
(1.06 to 1.76)
0.017
1.30
(1.00 to 1.68)
0.049
60 months n=926 1.12
(0.85 to 1.47)
0.427
1.14
(0.86 to 1.51)
0.356
1.24
(0.93 to 1.66)
0.146
1.26
(0.93 to 1.69)
0.136
1.19
(0.88 to 1.62)
0.254
*Mental Health Act Section.
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most strongly predicted by recorded poor insight when 
measured within the first 36 months, although associa-
tions persisted at statistical significance over 48 months 
(table 4). Higher number of inpatient days, however, 
was only significantly associated with poor insight when 
measured within the first 12 months (table 5). For propor-
tions of patients (with present or absent poor insight) and 
each clinical outcome at 12, 24, 36, 48 and 60 months, 
please see online supplementary table 1.
DIsCussIOn
In a large cohort of cases with first-episode psychosis 
drawn from a mental healthcare database, we developed 
Table 4 Association between insight and number of unique antipsychotics prescribed (Poisson regression)
Incidence rate ratio for the association with insight (95% CIs, p value)
Time period 
evaluated Unadjusted
Adjusted age and 
gender
Adjusted age, 
gender, ethnicity, 
relationship
Adjusted age, 
gender, ethnicity, 
relationship, 
employment, 
accommodation
Adjusted age, 
gender, ethnicity, 
relationship, 
employment, 
accommodation, 
diagnosis
12 months n=2026 1.27
(1.18 to 1.36)<0.001
1.27
(1.18 to 1.36)
<0.001
1.25
(1.16 to 1.34)
<0.001
1.26
(1.17 to 1.35)<0.001
1.24
(1.15 to 1.33)
<0.001
24 months n=1738 1.20
(1.12 to 
1.29) <0.001
1.20
(1.12 to 
1.29) <0.001
1.19
(1.11 to 
1.27) <0.001
1.20
(1.12 to 
1.29) <0.001
1.18
(1.10 to 1.26)
 <0.001
36 months n=1461 1.15
(1.08 to 
1.24) <0.001
1.15
(1.07 to 
1.24) <0.001
1.15
(1.10 to 1.23)<0.001
1.16
(1.08 to 1.25)<0.001
1.13
(1.05 to 
1.22) <0.001
48 months n=1185 1.10
(1.02 to 1.18)
0.016
1.10
(1.02 to 1.19) 0.012
1.01
(1.02 to 1.19) 0.013
1.11
(1.03 to 1.20) 0.006
1.09
(1.01 to 1.17)  0.034
60 months n=926 1.07
(0.98 to 1.16) 0.133
1.07
(0.98 to 1.16) 0.141
1.08
(0.99 to 1.18) 0.062
1.09
(1.00 to 1.19) 0.043
1.06
(0.98 to 1.16) 0.153
Table 5 Association between insight and days spent hospitalised during the observation period (linear regression)
B-coefficient for the association with recorded poor insight (95% CIs, p value)
Time period 
evaluated Unadjusted
Adjusted age and 
gender
Adjusted age, 
gender, ethnicity, 
relationship
Adjusted age, 
gender, ethnicity, 
relationship, 
employment, 
accommodation
Adjusted age, 
gender, ethnicity, 
relationship, 
employment, 
accommodation, 
diagnosis
12 months n=2026 9.57
(5.12 to 14.0)
<0.001
9.76
(5.30 to 14.2)
<0.001
9.46
(5.00 to 13.9)
<0.001
9.80
(5.24 to 14.4)
<0.001
9.12
(4.52 to 13.7)
<0.001
24 months n=1738 7.00
(−1.52 to 15.5)
0.107
7.73
(−0.79 to 16.3)
0.075
7.71
(−0.81 to 16.2)
0.076
8.12
(−0.58 to 16.8)
0.067)
6.56
(−2.20 to 15.3)
0.142
36 months n=1461 4.54
(−8.15 to 17.2)
0.483
6.06
(−6.61 to 18.7)
0.348
6.70
(−5.93 to 19.3)
0.298
6.57
(−6.26 to 19.4)
0.316
4.17
(−8.75 to 17.1)
0.527
48 months n=1185 −0.06
(−17.6 to 17.5)
0.994
3.03
(−14.5 to 20.6)
0.735
4.84
(−12.6 to 23.0)
0.586
5.22
(−12.4 to 22.8)
0.561
1.50
(−16.2 to 19.2)
0.868
60 months n=926 −2.17
(−25.4 to 21.0)
0.854
0.07
(−23.1 to 23.3)
0.995
5.74
(−17.3 to 28.8)
0.625
4.21
(−19.0 to 27.4)
0.722
−1.01
(−24.3 to 22.3)
0.932
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an algorithm to detect recorded poor insight and inves-
tigated this as a predictor of four subsequent service use 
outcomes. Rate of poor insight in our cohort (48.9%) 
was in the range of that reported by studies assessing it 
through routine data collection methods (~50%).29–32 
Poor insight was, in summary, significantly and inde-
pendently associated with higher number of hospital-
isation episodes overall, higher odds of legally enforced 
hospitalisation, higher numbers of days spent as an inpa-
tient and higher numbers of unique antipsychotic agents 
prescribed. Associations with these outcomes were stron-
gest when evaluated over the first 12 months of mental 
health service contact.
Loss of insight has long been considered a potentially 
important feature of psychotic disorders, and clearly 
establishing a therapeutic alliance is more challenging 
when insight is poor, accounting for associations found 
with reduced treatment adherence.7 8 On the other 
hand, reduced awareness of a mental disorder has been 
suggested to a reduced personal impact of that disorder, 
accounting for associations found with better self-rated 
quality of life10 11 and lower risk of depression and suicid-
ality.12–14 It is therefore understandable that there has 
been some controversy over whether poor insight has 
prognostic relevance. Our study focused on a range of 
outcomes derived from mental healthcare records and, 
as described above, found these to be worse in people 
recorded as having poor insight early in the course of 
their care.
Several factors were associated with recorded insight. 
Better insight in people who used cannabis or had 
drug-induced psychosis is potentially interesting, as it 
suggests that psychotic symptoms in these patients may 
be less enduring and time limited in association with 
substance use so that by the time they are assessed, they 
have insight into the likely link between illicit substances 
and psychotic disorder. Further research might helpfully 
investigate cannabis discontinuation to establish whether 
patients who continue using cannabis have less insight 
than those who do not. Better insight in bipolar disorder 
could reflect the episodic nature of the illness.
Strengths of the study include the large sample size 
and naturalistic nature of the cohort and follow-up. It 
has also demonstrated the great potential for natural 
language processing (NLP)applied to routine health-
care records in deriving novel information of clinical 
relevance. However, key limitations need to be borne 
in mind when interpreting the findings. Considering 
the measurement of insight, the performance of the 
NLP algorithm was judged to be satisfactory and clearly 
represents an important step forward in routine data 
collection (structured fields in case records invariably 
fail to record this construct thus rendering it invisible in 
conventional healthcare databases); furthermore, subop-
timal measurement of insight would have obscured 
rather than exaggerated the prospective associations with 
the outcomes of interest. However, clearly statements 
about insight have to be recorded in the first place, and 
there may be clinical circumstances and reasons which 
render these more or less likely. For example, clinicians 
may be biased to record insight when it is poor or notice-
ably absent but not when it is present. In addition, as we 
measured insight as a fixed binary variable, the construct 
cannot be assumed to be identical to an assessment of 
insight in a research interview, and we solely focused on 
recorded poor insight and did not seek to subcharac-
terise the sample into those with mixed good or poor 
statements. Additionally, the precision and recall rates 
still allow for a risk of false positive and false negative 
instances of poor insight, and further work could be 
employed to improve the performance metrics. In terms 
of follow-up, hospitalisations and other outcomes would 
only be ascertained for those cases which remained in 
the geographic catchment served by SLaM, so outmigra-
tion might have affected longer interval findings. In this 
analysis, as with a previous analysis of cannabis use as a 
risk factor in this sample,22 we investigated associations 
over different time periods. Longer follow-up evaluations 
clearly provide a more informed picture of prognosis; 
however, insight cannot be assumed to be constant over 
time, and we did not attempt to quantify these trajecto-
ries—for example, more effective treatment may result 
in a virtuous cycle involving improved insight and better 
therapeutic engagement.
Residual confounding cannot be absolutely excluded, 
and causal pathways also remain to be elucidated; 
however, these might include failure to establish initial 
engagement with services resulting in symptomatic dete-
rioration and requirement for inpatient care—partic-
ularly supported by the higher use of legally enforced 
hospitalisation. It is possible that poor insight at first 
presentation is associated with antipsychotic treatment 
failure, as suggested by the higher number of antipsy-
chotics used, although it is difficult to draw this conclu-
sion with certainty because of potentially complex 
interactions between insight and treatment effects. Poor 
insight might place strains on social support networks and 
compromise the role of protective factors, accounting 
for the observed associations between poor insight and 
indicators of social/financial disadvantage in our cohort. 
It might result in risk behaviours which result in worse 
outcomes, although we adjusted for cannabis use as one 
of these potential pathways, and this did not account 
substantially for the associations observed. Finally, it is 
possible that poor insight is not a risk factor itself but 
is a marker of a disorder which is already more severe 
in other respects (such as symptomatically or in terms 
of functional deterioration). Importantly, this study 
focused on the relationship between insight recorded 
shortly after presentation and the outcomes of interest, 
and we did not seek to capture changes in insight over 
the follow-up periods; this would be a potentially useful 
further line of enquiry, although dependent on the 
extent to which fluctuations in insight are recorded in 
routine mental healthcare.
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COnClusIOn
Our findings do support an important prognostic role 
for poor insight in people with psychotic disorders when 
this is mentioned early after first clinical presentation. 
Although economic modelling was not attempted, clearly, 
outcomes such as the number and duration of hospital-
isation episodes have substantial impact, and measures 
taken to improve insight might similarly bring important 
benefits at a service level as well as on individuals’ course 
of illness.
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